Mar 03, 2021 / 05:20PM GMT
Kenneth Charles Cacciatore - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Thanks, everyone, for joining us. Thanks for Jack for being here and Stacy and Georgi with me today virtually, looking forward to seeing everyone next year live in Boston. But been a good substitute to be able to get everyone at least on the screens together.
Jack thanks, it's been a long time that we've known each other, been working with each other and seeing the evolution of the company from no commercial assets to really done a fantastic job with the original assets that you have.
And now you added WorldMeds and real exciting to talk about today 812. I thought it would be helpful to folks, clearly, I know your background, but maybe some that don't -- as it relates to the genesis of Supernus vis-Ã -vis some of the background you have in ADHD. I always find it helpful to rehear it, maybe it would be good for other folks to understand a little bit of the background before we set up a discussion on 812. So with that kind of open-ended comment, I'll throw it to you to just talk about
Supernus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers